Publication
Conversion to sirolimus ameliorates cyclosporine-induced nephropathy in the rat – focus on serum, urine, gene and protein renal expression biomarkers
dc.contributor.author | Sereno, José | |
dc.contributor.author | Nunes, Sara | |
dc.contributor.author | Rodrigues-Santos, Paulo | |
dc.contributor.author | Vala, Helena | |
dc.contributor.author | Rocha-Pereira, Petronila | |
dc.contributor.author | Fernandes, João | |
dc.contributor.author | Santos-Silva, Alice | |
dc.contributor.author | Teixeira, Frederico | |
dc.contributor.author | Reis, Flávio | |
dc.date.accessioned | 2014-06-02T08:57:44Z | |
dc.date.available | 2014-06-02T08:57:44Z | |
dc.date.issued | 2014 | |
dc.description.abstract | Protocols of conversion from cyclosporine A (CsA) to sirolimus (SRL) have been widely used in immunotherapy after transplantation to prevent CsA-induced nephropathy, but the molecular mechanisms underlying these protocols remain nuclear. This study aimed to identify the molecular pathways and putative biomarkers of CsA-to-SRL conversion in a rat model. Four animal groups (𝑛 = 6) were teste during 9 weeks: control, CsA, SRL, and conversion (CsA for 3 weeks followed by SRL for 6 weeks). Classical and emergent serum, urinary, and kidney tissue (gene and protein expression) markers were assessed. Renal lesions were analyzed in hematoxylin and eosin, periodic acid-Schiff, and Masson’s trichrome stains. SRL-treated rats presented proteinuria and NGAL (serum and urinary) as the best markers of renal impairment. Short CsA treatment presented slight or even absent kidney lesions and TGF- β , NF-𝜅β , mTOR, PCNA, TP53, KIM-1, and CTGF as relevant gene and protein changes. Prolonged CsA exposure aggravated renal damage, without clear changes on the traditional markers, but with changes in serums TGF-β and IL-7, TBARs clearance, and kidney TGF- β and mTOR. Conversion to SRL prevented CsA-induced renal damage evolution (absent/mild grade lesions), while NGAL (serum versus urine) seems to be a feasible biomarker of CsA replacement to SRL | por |
dc.description.sponsorship | This work was supported by the Ph.D. research Grant from the Portuguese Foundation for Science and Technology (SFRH/BD/63962/2009), Strategic Project PEst-C/SAU/UI- 3282/2011-COMPETE. | por |
dc.identifier.citation | José Sereno, Sara Nunes, Paulo Rodrigues-Santos, Helena Vala, Petronila Rocha-Pereira, João Fernandes, Alice Santos-Silva, Frederico Teixeira, Flávio Reis (2014). Conversion to sirolimus ameliorates cyclosporine-induced nephropathy in the rat – focus on serum, urine, gene and protein renal expression biomarkers. BioMed Research International. Volume 2014. 17 pp. Article ID 576929, http://dx.doi.org/10.1155/2014/576929 17 pages Impact Factor 2.880 (2012) | por |
dc.identifier.uri | http://hdl.handle.net/10400.19/2180 | |
dc.language.iso | eng | por |
dc.peerreviewed | yes | por |
dc.subject | Cyclosporine A | por |
dc.subject | Transplantation | por |
dc.subject | Sirolimus | por |
dc.title | Conversion to sirolimus ameliorates cyclosporine-induced nephropathy in the rat – focus on serum, urine, gene and protein renal expression biomarkers | por |
dc.type | journal article | |
dspace.entity.type | Publication | |
person.familyName | Vala Correia | |
person.givenName | Helena Maria | |
person.identifier.ciencia-id | 7A1E-E85E-FFA4 | |
person.identifier.orcid | 0000-0001-6829-4867 | |
rcaap.rights | openAccess | por |
rcaap.type | article | por |
relation.isAuthorOfPublication | cdc3d2e2-df06-40ed-8900-1ecbc8a06c8a | |
relation.isAuthorOfPublication.latestForDiscovery | cdc3d2e2-df06-40ed-8900-1ecbc8a06c8a |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- 12 Conversion Sirolimus Sereno et al BioMed Res Intern 14.pdf
- Size:
- 7.73 MB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: